Matching geography

Reports matching your search in:
 
 

Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!
Region: All Regions > Asia
Category: All Categories > Life Sciences > Healthcare
(541 reports matching your criteria)
 
< prev 1  2  3  4  5  6  7  8  9  10  next >
Singapore Healthcare Industry 2H12
1/14/2013 | published by: Emerging Markets Direct Reports
... centric initiative, and national electronic health records, plus the profile, comparative matrix and SWOT of the industry leading players: Parkway Holdings Ltd (Parkway), Thomson Medical Centre (TMC), Health Management International Ltd (HMI), and China Healthcare ...  |  more...
$480.00
Indonesia Pharmaceuticals & Healthcare Industry 2H12
1/14/2013 | published by: Emerging Markets Direct Reports
... support and pharmaceutical trade. It also covers the market trends and outlook, regulatory changes, counterfeit drugs, industry SWOT analysis and market outlook, plus profile, comparative matrix and SWOT analysis of the leading players: PT Kalbe ...  |  more...
$450.00
Kazakhstan Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... logistical challenges. In the short term, Kazakhstan's marketdevelopment is driven by a balanced policy of import substitution and integration into regional (CustomsUnion) and global (World Trade Organisation) systems. Over the longer term, the country could ...  |  more...
$1,175.00
Hong Kong Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... comparison to regional peers such as Singapore, Taiwan,China and South Korea means that the attractiveness of the market will dwindle over the longer term,should other developing countries such as Indonesia, Malaysia and the Philippines succeed ...  |  more...
$1,175.00
Japan Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... and will seek to save costs through the use of more genericdrugs and price cuts. Nevertheless, the current profile broods well for generic drugmakers as well ascompanies focusing on eldercare and chronic disease management. Headline ...  |  more...
$1,175.00
Taiwan Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... Generation National Health Insurance (NHI) programme, whichbecomes effective in 2013, a new reimbursement system is expected to be rolled out in Taiwan. TheAmerican Chamber of Commerce in Taipei (AmCham), in its latest White Paper published ...  |  more...
$1,175.00
Research Report on China's High-end Medical Treatment Industry, 2013-2017
12/14/2012 | published by: China Research and Intelligence Co., Ltd.
... medical services and they are unwilling to accept the noisy and crowded hospital environment and inferior service attitudes of public hospitals. Insensitive to prices or enjoying high-end medical insurances, they can afford high medical expenses. ...  |  more...
$2,800.00
Turkey Pharmaceuticals and Healthcare Report Q1 2013
12/12/2012 | published by: Business Monitor International
... various insuranceand immunisation schemes. Price cutting and public discount decrees announced in November 2011continue to affect the pharmaceutical market in 2012, as highlighted by the decrease in pharmaceuticalspending in the first half of this year. ...  |  more...
$1,175.00
Thailand Pharmaceuticals and Healthcare Report Q1 2013
12/12/2012 | published by: Business Monitor International
... issues such as the shortage of medical professionals and hospital overcrowding, given that theseproblems existed when the scheme was first implemented. We highlight that universal healthcarecoverage will prove to be financially unsustainable in the long ...  |  more...
$1,175.00
Pakistan Pharmaceuticals and Healthcare Report Q1 2013
12/12/2012 | published by: Business Monitor International
... professionals to effectively monitor the costly andtimely process, while patients would benefit from more rapidly introduced pharmaceuticals. Drugmakerswould also see higher commercial upside if the requirements were withdrawn. Headline Expenditure Projections Pharmaceuticals: PKR171.20bn (US$1.98bn) in ...  |  more...
$1,175.00
Asia/Pacific Healthcare 2013 Top 10 Predictions
12/9/2012 | published by: IDC
... acquisition, implementation, and use of technology by healthcare providers for the delivery and management of care both within the hospitals, as well as through the care continuum. It also seeks to address key issues, drivers, ...  |  more...
$4,500.00
China Wellness Industry Outlook 2016 - Potential Opportunities in Tier-2 and Tier-3 Cities in China
12/1/2012 | published by: Ken Research
... health clubs, spa, cosmetic products, beauty salons and nutrition and dietary supplements market in China. The report also covers the revenue generated by the wellness industry as well the market prospects and future opportunities. The ...  |  more...
$800.00
Healthcare, Regulatory and Reimbursement Landscape - Turkey
11/30/2012 | published by: GlobalData
... Turkey’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights ...  |  more...
$1,995.00
China Healthcare Industry IoT (M2M) Market Study
11/28/2012 | published by: IDC
... Location-based service (LBS) solution, drug transportation tracking solution, clinical IoT solution, and consumer health monitoring IoT solution are the four major adoption models of IoT in China's healthcare industry. Among these four models, LBS solution ...  |  more...
$3,500.00
Top 100 Korean Hospitals (Korea)
11/19/2012 | published by: Plimsoll Publishing Ltd.
... to industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new report: 58 of ...  |  more...
$1,050.00
Top 1000 Hospitals (Asia)
11/19/2012 | published by: Plimsoll Publishing Ltd.
... industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new report: 345 of the ...  |  more...
$1,300.00
Top 300 Veterninary Medicine Manufacturers (China)
11/19/2012 | published by: Plimsoll Publishing Ltd.
... compared to industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new report: 38 ...  |  more...
$1,000.00
Top 39 Indian Hospitals (India)
11/19/2012 | published by: Plimsoll Publishing Ltd.
... to industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new report: 8 of ...  |  more...
$1,050.00
2012 China New Medical Reform Policy Specific Analysis and the Influence on Medical Industry
11/14/2012 | published by: Huidian Research
... on provinces added list. Besides, it also had a specific analysis on marketing channel of China medicine enterprises under New Medical Reform Policy. Generally, the report can provide advantageous reference for insiders and help you ...  |  more...
$2,600.00
Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation
11/9/2012 | published by: GBI Research
... research, “Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation”. The report provides key data, information and analysis of the major ...  |  more...
$3,500.00
Russia Pharmaceuticals and Healthcare Report Q4 2012
11/7/2012 | published by: Business Monitor International
... the sector, on both the production side and as a purchaser of medicines hasexpanded the size of the market, although it has equally imposed more onerous regulations in what wasonce a fairly liberal pricing environment. ...  |  more...
$1,175.00
RMGL - Raffles General Hospital Development - China - Construction Project Profile
11/6/2012 | published by: World Market Intelligence
... funding, gives a full project description, as well as information on contracts, tendering and key project contacts. The RMGL - Raffles General Hospital Development - China - Construction Project Profile is part of World Market ...  |  more...
$75.00
China Pharmaceuticals & Health Care Industry 2H12
11/6/2012 | published by: Emerging Markets Direct Reports
... trends and outlook, social health care insurance system, traditional Chinese medicine, over-the-counter and vaccines, plus the profile, comparative matrix and SWOT analysis of the industry leading players: Shanghai Pharmaceuticals Holding Co. Ltd., China National Accord ...  |  more...
$480.00
Indian Healthcare Industry Deal Directory - Edition Q2'2012
11/1/2012 | published by: Ken Research
... Laboratories, Medical Devices, Skin and Personal Care, Diagnostic Services, Contract Research and Manufacturing Services (CRAMS), Clinical Research, Fitness and Recreational Sports Centers, Animal Healthcare, Nutrional Supplements, Hospitals and Nursing Centres, Healthcare Business Support Services, Medical ...  |  more...
$350.00
Indonesia Pharmaceuticals and Healthcare Report Q4 2012
10/31/2012 | published by: Business Monitor International
... to run the national healthcare programme, or risk theprogramme failing according to Hotbonar Sinaga of the University of Indonesia and Bambang Purwokoof the Pancasila University, cited by the Jakarta Post. In the meantime, innovative drugmakers ...  |  more...
$1,175.00
< prev 1  2  3  4  5  6  7  8  9  10  next >